Wilma Lukas

Wilma (PhD, MBA) has over 25 years of experience in drug discovery, R&D, licensing and business development in the pharmaceutical industry (GSK, Merck, Debiopharm). She is providing strategic advice and expert scientific opinion to biotech companies, start-ups, universities, investors and pharmaceutical companies. She is acting as a Board Expert for the Skolkovo Foundation, Expert at Innosuisse and Associate Partner at <bba>, a strategic consultancy company.